Tolvaptan Tablet
NDC Package 31722-868-03
Package Information
Tolvaptan tablets are indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction), including patients with heart failure and Syndrome of Inappropriate Antidiuretic Hormone (SIADH). This formulation utilizes a tablet delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-868 and is authorized under FDA application ANDA205646.
Identification & Billing
- RxCUI: 849827 - tolvaptan 15 MG Hyponatremia Oral Tablet
- RxCUI: 849827 - Hyponatremia tolvaptan 15 MG Oral Tablet
- RxCUI: 849833 - tolvaptan 30 MG Hyponatremia Oral Tablet
- RxCUI: 849833 - Hyponatremia tolvaptan 30 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31722 - Camber Pharmaceuticals, Inc.
- 31722-868 - Tolvaptan
- 31722-868-03 - 1 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
- 31722-868 - Tolvaptan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (31722-868). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31722-868-03 identifies a specific commercial package of 1 blister pack in 1 carton / 10 tablet in 1 blister pack of Tolvaptan, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains tolvaptan as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on September 06, 2022. The current certification is valid through December 31, 2027.
How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722086803. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.